Schematic illustration of the plasmid constructs pGFPPTM-NC and p53-cDNA, which are used as the control for p53PTM-E7-11. pGFPPTM-NC contained CMV promoter, binding domain, spacer, branch point, poly-pyrimidine tract, splice acceptor site, eGFP acceptor (GenBank accession # U55763.1 nt 995-1410) and Flag-tag. GFP-PTMs pair specifically with intron 6 of p53 gene, and then replace mutant piece of p53 mRNA with GFP acceptor to produce a hybrid transcripts of exons 1-6 of p53 mRNA and GFP acceptor. The plasmid of p53 cDNA contained CMV promoter, p53 cDNA (GenBank accession # NM_000546 nt 198-1379) and Flag-Tag, which was used as a positive control.
Supplementary Methods

Cell culture
Human hepatocellulae cancer cells HepG2 (ATCC HB-8065) , PLC/PRF/5 (ATCC CRL8024 ) were cultured in DMEM, supplemented with 10% fetal bovine serum, 100 units/mL of penicillin, and 100 μg/mL of streptomycin at 37°C in a humidified atmosphere of 5% CO2. Normal hepatocyte L02 cells were cultured in 1640 supplemented with 10% fetal bovine serum. PLC/PRF/5 contains p53 mutation in codon 249 (R249S).
HepG2 is a HCC cell line expressing wild-type p53; L02 is a normal hepatic cell line that expresses wild-type p53.
Trans-splicing cassette
As shown in Figure 1 , the plasmid carrying p53 pre-trans-splicing molecule included CMV promoter, a binding domain, the splice elements, a coding domain and and Flag-tag.
The spacer was comprised of a de novo sequence (5'-GCGGCCGCCCGAATAA GTGATTGA TTGAG TTT-3'), that is non-homologous to any murine or human sequence.
This was followed by the artificial branch point and polypyrimidine tract and splice acceptor sequence (5'-TACTAACTGAT ATCTCT TCTTTTTTTTTTT CCGGA AAACAG-3') as described previously [1] [2] [3] . The sequence of FLAG-tag is 5' GAC TAC AAG GAC GAC GAC GAC AAG -3'. In this study, the plasmids (pGFPPTM-NC and p53-cDNA) encoding GFP pre-trans-splicing molecule or p53 cDNA were constructed as the controls of p53PTM-E7-11 (Supplementary Figure S1 ). All the plasmids were based on a backbone derived from the pcDNA3.1(+) vector (Invitrogen, Carlsbad, CA). For pGFP-PTM ( Figure S1 ), the only difference between pGFPPTM-NC and p53PTM-E7-11 was that eGFP acceptor (GenBank accession # U55763.1 nt 995-1410) in pGFP-PTM replaced exons 7-11 of p53 cDNA in p53PTM-E7-11. For the plasmid expressing p53 cDNA, p53 cDNA were obtained by RT-PCR and then cloned in to pcDNA3.1(+) vector backbone. As shown in Figure S1 , Flag-tag followed by p53 cDNA was added into the vector. All the primers used for plasmids construction were listed in Supplementary Table S1 .
RT-PCR and Real-time PCR
Total RNA (5 µg) were extracted from the cells or the tissues and reverse transcribed into cDNA using PrimeScript RT reagent Kit (DRR037S; Takara, Dalian, China). The cDNAs were used as templates for subsequent PCR using the Platinum PCR SuperMix High Fidelity (Invitrogen, Carlsbad, California, USA). To detect trans-spliced p53 transcripts in transfected or infected cells, PCR was done using the primers specific to exon 4 and Table S1 ). The PCR products were purified by gel extraction kit, and sequenced. Real-time PCR was performed using SYBR Green PCR Kit (Applied Biosystems, Foster City, CA). △△ Data analysis was performed using the 2 Ct method.
Flag-tag (Supplementary
Each sample was tested in triplicate. Threshold values were determined for each sample and average and standard error values were calculated. mRNA levels were normalized to the level of GAPDH in the same sample. Primers used were listed in the Supplementary   Table S2 .
TUNEL Staining
PLC/PRF/5 cells grown on chamber slides were transfected with p53-PTM or the controls.
After 48 hours, cells were fixed using 2% paraformaldehyde and TUNEL staining was performed by terminal deoxynucleotidyl transferase-mediated nick end labeling staining (In Situ Cell Death Detection kit, Fluorescein, Roche Diagnostics, Mannheim, Germany).
Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI). Then, two independent investigators, blinded to the treatment, evaluated the relative number of apoptotic cells per well by counting 4 randomly selected high-power fields.
Western blot
Lysates from the cells or the tissues were collected using RIPA buffer (Sigma R0278, St
Louis, MO, USA). The lysates were resolved over SDS-polyacrylamide gels, and blotted onto polyvinylidene difluoride membrane. The specimens were immunoblotted with primary antibodies, then with peroxidase-conjugated secondary antibodies. 
Cell cycle and cell apoptosis assay
Cell cycle was analyzed using propidium iodide DNA staining. In brief, transfected cells were harvested, and fixed with 70% ethanol. After the incubation with ribonuclease, the specimens were stained with propidium iodide. The results were evaluated by flow cytometry. Cell apoptosis was detected using Annexin V FITC apoptosis detection Kit 
Cell proliferation
Cell proliferation was evaluated by CellTiter 96 aqueous one solution cell proliferation assay kit (Promega, USA). In brief, the transfected cells were incubated with the CellTiter One Solution Reagent, and the absorbance was measured at 490 nm.
Luciferase assay
PLC/PRF/5 cells seeded in 96-well plates were transiently transfected with 0.1 µg p53PTM-E7-11 or the control plasmids, 0.1 µg luciferase reporter constructs, and 0.01µg of pMIR-REPORTTM β-gal plasmid as an internal control for transfection efficiency. At 48 h after transfection, luciferase and β--galactosidase activities were measured using the Dual-Light System (Applied Biosystems) as we have described before 4 . The following reporter constructs of promoter were used in transfection experiments:
pcyclinA-prom-LUC (Constructed by ourselves, as described by Henglein et al) 5 , pcyclinB-prom-LUC (provided by Prof Giulia Piaggio, Experimental Oncology Department, Istituto Regina Elena, Italy) 6 , pcyclin D-prom-LUC (32727, Addgene) 7 , pcyclin E-prom-LUC (8458, Addgene) 8 , pP21/WAF1-prom-LUC (16451, Addgene 9 , pBCL2-prom-LUC (15393, Addgene) 10 , pPUMA-prom-LUC (16591, Addgene) 11 .
Production of recombinant adenovirus and cell infection
Trans-splicing expression cassettes containing one binding domain, the splice elements, a coding domain (exons 7-11 of p53 cDNA) and Flag-tag were cloned into shuttle plasmid 
Statistical assessment
All data are expressed as mean ± standard error from 3 separate experiments performed in triplicate except otherwise noted. Differences between means were analyzed by Student's t-test and P < 0.05 was considered to be statistically significant. 
